Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

No treatment alters the natural progression of alopecia areata, and effectiveness varies, with some possibly working better in children.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Obesity is linked to various skin conditions and issues, and losing weight can improve these conditions.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Bexarotene gel shows promise as a new treatment for alopecia areata.

A patient with complete hair loss regrew all her hair using tofacitinib.

Oral isotretinoin does not cause milia in acne patients.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.